ABCB1 expression has been shown in many cancer types; however, ABCB1 modulation therapy has not been effective against tumours that possess ABCC family-mediated drug resistance, as shown for the doxorubicin-selected lung cancer cell line H69AR and HL60/AR [53]. This evidence concerns the gene ABCB1 and lung carcinoma.